BioMarin Pharmaceutical Inc. (0HNC.L) LSE

60.04

-0.53(-0.88%)

Updated at December 24 05:50PM

Currency In USD

Valuation

Market Cap12.49B
Enterprise Value12.18B
P/E Ratio22.2
PEG Ratio-1.05
Price/Sales Ratio3.74
Price/Book Ratio1.91
Enterprise/Revenue3.52
Enterprise/EBITDA14.12

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.17
Operating Margin0.2

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue2.85B
Revenue/Share16.11
Gross Profit2.27B
EBITDA650.53M
Net Income426.86M
Diluted EPS2.21

Balance Sheet

Total Cash1.48B
Total Cash/Share7.7
Total Debt596.66M
Total Debt/Equity0.1
Current Ratio4.83
Book Value Per Share31.54

Price History

52-Week Change-9.93
52-Week High99.65
52-Week Low59.94
Moving Average 50 Days90.32
Moving Average 200 Days89.61

Statistics

Average Volume5,967
Shares Outstanding192.13M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A